BWL
PCVX icon

Bogart Wealth LLC’s Vaxcyte PCVX Stock Holding History

Bogart Wealth LLC’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581 Buy
10
+2
+25% +$109 ﹤0.01% 1743
2026
Q1 		$465 Sell
8
-7
-47% -$380 ﹤0.01% 1615
2025
Q4 		$692 Hold
15
– – ﹤0.01% 1386
2025
Q3 		$540 Hold
15
– – ﹤0.01% 1396
2025
Q2 		$488 Buy
+15
New +$492 ﹤0.01% 1356

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Bogart Wealth LLC's PCVX Position: Q2 2026 in Review

Bogart Wealth LLC increased its Vaxcyte (PCVX) stake by 25% in Q2 2026, buying an estimated $109 and bringing the position to 10 shares worth $581. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Bogart Wealth LLC first reported a position in PCVX in Q2 2025 and has held it in 5 quarters since. The position peaked at $692 in Q4 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Bogart Wealth LLC held 10 shares of Vaxcyte worth $581 as of Q2 2026.
  • Bogart Wealth LLC bought 2 Vaxcyte shares in Q2 2026, an estimated $109.
  • Vaxcyte made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1743 holding.
  • Bogart Wealth LLC first reported a position in Vaxcyte in Q2 2025 and has held it in 5 quarters since.
  • Bogart Wealth LLC's Vaxcyte position peaked at $692 in Q4 2025.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.